Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Duration of Human Papilloma Virus (HPV) Type-Specific Antibody After Administration of Quadrivalent HPV Vaccine (QHPV) to HIV-1 Infected Children Previously Enrolled in IMPAACT P1047

NCT01206556 is registered in ClinicalTrials.gov with International Maternal Pediatric Adolescent AIDS Clinical Trials Group as lead sponsor.

NCT NCT01206556
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01206556 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Duration of Human Papilloma Virus (HPV) Type-Specific Antibody After Administration of Quadrivalent HPV Vaccine (QHPV) to HIV-1 Infected Children Previously Enrolled in IMPAACT P1047
Lead sponsor
International Maternal Pediatric Adolescent AIDS Clinical Trials Group
Phase
Observational
Overall status
Completed
Start date
May 31, 2010
Completion date
August 31, 2013
Enrollment
97 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

papilloma virus, human